Century Therapeutics: Funding, Investors & Team (Aug 2026)
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer. The company's genetically-engineered, iPSC-derived immune effector cell products are designed to specifically target hematologic and solid cancers by harnessing the power of adult stem cells, providing patients with an unparalleled opportunity to advance the course of cancer care.
Century Therapeutics has raised $160M across 1 funding round on record, the most recent a Series C of $160M announced in Mar 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Century Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2021.
Century Therapeutics Funding Rounds
Century Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Century Therapeutics Funding Compared to Other Biotechnology Startups
Century Therapeutics' latest round of $160M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Century Therapeutics in Biotechnology and Philadelphia
Companies Similar to Century Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Century Therapeutics Funding FAQs
What does Century Therapeutics do?
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer. The company's genetically-engineered, iPSC-derived immune effector cell products are designed to specifically target hematologic and solid cancers by harnessing the power of adult stem cells, providing patients with an unparalleled opportunity to advance the course of cancer care.
How much funding has Century Therapeutics raised?
Century Therapeutics has raised $160M across 1 round on record. The most recent is a Series C of $160M announced in Mar 2021.
When did Century Therapeutics last raise funding?
Century Therapeutics' most recent funding round on record is a Series C of $160M, announced in Mar 2021.
Who is the CEO of Century Therapeutics?
Osvaldo Flores is listed as CEO at Century Therapeutics.
Where is Century Therapeutics headquartered?
Century Therapeutics is based in Philadelphia, Pennsylvania, United States.
How many employees does Century Therapeutics have?
Century Therapeutics is in the 101-250 employee band.
How does Century Therapeutics' funding compare to other Biotechnology startups?
Century Therapeutics' latest round of $160M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Century Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Century Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.